首页> 美国卫生研究院文献>Annals of Intensive Care >Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

【2h】

Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

机译：人类可溶性血栓调节蛋白（ART-123）治疗法国患者患有脓毒症相关凝血病的疗效和安全性：猩红色后的HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version contains supplementary material available at 10.1186/s13613-021-00842-4.

机译：在线版本包含10.1186 / s13613-021-00842-4的补充材料。

著录项

期刊名称 Annals of Intensive Care
作者
Bruno François; Maud Fiancette; Julie Helms; Emmanuelle Mercier; Jean-Baptiste Lascarrou; Toshihiko Kayanoki; Kosuke Tanaka; David Fineberg; Jean-Louis Vincent; Xavier Wittebole;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
Sepsis; Sepsis-associated coagulopathy; Thrombomodulin; ART-123; Heparin; France;

机译：败血症;败血症相关的凝血病;血栓调节蛋白;ART-123;肝素;法国;

相似文献

外文文献
中文文献
专利

1. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy The SCARLET Randomized Clinical Trial [J] . Lobo Suzana M., Barie Philip S., Crowther Mark, JAMA: the Journal of the American Medical Association . 2019,第20期

机译：重组人类可溶性血栓调节素对脓毒症相关凝血病患者死亡率的影响猩红色随机临床试验
2. A randomized, double-blind, placebo-controlled, phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation [J] . VincentJ.-L., RameshM.K., ErnestD., Critical care medicine . 2013,第9期

机译：一项随机，双盲，安慰剂对照的2b期研究，用于评估重组人可溶性血栓调节蛋白ART-123在脓毒症和疑似弥散性血管内凝血患者中的安全性和有效性
3. A randomized, double-blind, placebo-controlled, phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation [J] . VincentJ.-L., RameshM.K., ErnestD., Critical care medicine . 2013,第9期

机译：一项随机，双盲，安慰剂对照的2b期研究，用于评估重组人可溶性血栓调节蛋白ART-123在脓毒症和疑似弥散性血管内凝血患者中的安全性和有效性
4. Study of Efficacy and Safety of Willow Bark Extract (Assalix) in Treatment of Chronic Low Back Pain in Patients of Different Age with Osteochondrosis [C] . V.V. Povoroznyuk, T.A. Karasevskaya International Pain Clinic Congress . 2008

机译：柳树皮提取物（Assalix）治疗不同年龄患者慢性低腰疼痛的疗效和安全性研究
5. Expression of interferon gamma by recombinant rabies virus strongly attenuates virus pathogenicity and enhances safety and efficacy of post-exposure treatment vectors. [D] . Barkhouse, Darryll. 2014

机译：重组狂犬病毒表达干扰素γ大大减弱了病毒的致病性，并提高了暴露后治疗载体的安全性和有效性。
6. Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis [O] . Kazuma Yamakawa, Jerrold H. Levy, Toshiaki Iba 2019

机译：败血症相关性凝血病（SCARLET）患者的重组人可溶性血栓调节蛋白：最新荟萃分析
7. Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long‐term extension studies over 7 years [O] . Arvind Chopra, Vineeta Shobha, Srikantiah Chandrashekara, 2020

机译：TOFACITINIB治疗印度类风湿性关节炎的患者：在7阶段和长期延伸研究中的疗效和安全性后的HOC分析

Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

摘要

著录项

相似文献

相关主题

期刊订阅